For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211124:nRSX3392Ta&default-theme=true
RNS Number : 3392T Transense Technologies PLC 24 November 2021
24 November 2021
Transense Technologies plc
("Transense" or the "Company")
Director/PDMR shareholding - acquisition of shares
Transense Technologies plc (AIM: TRT), the developer of specialist sensor
systems, has been notified that on 23 November 2021 Ryan Maughan, who will
join the board with effect from 1 December 2021, purchased 7,086 ordinary
shares in the Company at £1.06p per share. Accordingly, Ryan Maughan's total
beneficial shareholding in the Company has increased to 12,251 ordinary
shares, which represents 0.075% of the issued share capital.
Further details are provided in the forms below in accordance with the
requirements of the UK Market Abuse Regulation.
For further information please visit www.transense.com or contact:
Transense Technologies plc
Nigel Rogers (Executive Chairman)
Melvyn Segal (CFO) Via Walbrook PR
Allenby Capital (Nominated Adviser and Broker)
Jeremy Porter / George Payne (Corporate Finance)
Tony Quirke (Sales and Corporate Broking) Tel: +44 (0)20
3328 5656
Walbrook PR
Tom Cooper/Nick Rome/Nicholas Johnson Tel: +44 (0)20 7933
8780
Transense@walbrookpr.com
Notes to Editors:
Transense is a developer of specialist wireless sensor systems used to
enable real-time data gathering and monitoring. Products include the
patent protected Surface Acoustic Wave (SAW) sensor technology, used to
improve equipment power, performance, reliability and efficiency; iTrack,
Transense's Tyre Pressure Monitoring System, licensed to Bridgestone
Corporation, the world's largest tyre producer, under a ten-year deal in June
2020; and a range of intelligent tyre monitoring equipment under the
Translogik brand. Target sectors include aerospace, automotive (high
performance and off-road) and complex machine control.
The Group's strategy is to maximise shareholder value through the delivery of
sustained revenue growth from all three principal technologies - SAW, iTrack
and Translogik probes - through leveraging excellence in innovation, know-how
in commercialising technologies, industry partnerships and exposure to global
growth markets.
Transense is headquartered in Oxfordshire, UK, and was admitted to trading on
AIM, a market operated by the London Stock Exchange (AIM: TRT), in
1999. www.transense.com (http://www.transense.com/)
For further information please contact transense@walbrookpr.com
(mailto:transense@walbrookpr.com) .
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Ryan Maughan
2 Reason for the notification
a) Position/status Director (designate)
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Transense Technologies plc
b) LEI 2138005N52J6KKQ3EY67
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 10 pence each
Identification code GB00BDHDTH21
b) Nature of the transaction Purchase of Ordinary Shares
c) Price and volume Price: 106 pence per share
Volume: 7,086
d) Aggregated information
- Aggregated volume As above
- Price
e) Date of the transaction 23 November 2021
f) Place of the transaction London Stock Exchange, AIM
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHPPGUGGUPGPUW